Aussie markets put up a broad-based rally today, with the S&P/ASX 200 climbing 1.74% to close at 8,728.80, effectively erasing its year-to-date losses to sit 1 point higher through 2026. The benchmark index briefly touched 8,800 during the session, while the broader All Ordinaries added 1.67% to finish at 8,921.20, having flirted with the psychologically significant 9,000 mark intraday.
The post-Easter bounce represented a decisive shift in sentiment, with sectors participating across growth-oriented tech names, cyclical materials, and the heavyweight financials sector.
ASX Today – Sector Leaders
Technology stocks led the charge, with the ASX 200 Information Technology index surging 3.98%, its strongest single-day performance in weeks. Data centre operator NEXTDC jumped 11.9% to $12.60 on an update, reinforcing its position as the local market’s premier play on artificial intelligence infrastructure demand.
Financials provided crucial support, advancing 2.16% as Bank of Queensland shares rallied 6.91% to $7.27, making a new 2026 high.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Materials climbed 2.61%, extending a multi-month uptrend that has seen the sector gain more than 40% since March 2024. Lynas Rare Earths advanced 4.59% to $20.30, while Alkane Resources added 4.36% to $1.555, both benefiting from the ongoing strategic focus on critical minerals supply chains outside China. The moves underscore the structural tailwind from electric vehicle production, defence spending, and energy transition policies that continue to support rare earths producers.
Laggards Signal Pockets of Caution
The rally was not uniform. Mesoblast tumbled 6.81% to $1.985, with the stem-cell biotech’s underperformance on a strong market day highlighting ongoing scepticism after a trading update. Ryman Healthcare fell 4.84% to $1.77, while property giant Stockland dropped 3.4% to $3.98, both reflecting persistent concerns about property-linked balance sheets in an environment where bond yields remain elevated and cap rates are under pressure.
Sonic Healthcare declined 2.5% to $19.48, a move that paradoxically reinforces the bullish narrative: when defensive healthcare names underperform on a strong day, it typically signals funds are rotating out of safety and into cyclicals and growth.
ASX 200 Outperforming All Ords This Year, But Will Bounce Continue
Today’s close brings the ASX 200 back to its opening level for calendar 2026, a symbolic milestone that removes the psychological weight of a year-to-date drawdown. However, the All Ordinaries remains 1.28% lower for the year, indicating that smaller and mid-cap stocks have yet to participate fully in the recovery. This divergence is typical of late-cycle markets, where liquidity concentrates in larger, more liquid names.
Breadth was strong today, with gains across multiple sectors rather than a narrow squeeze, which typically supports follow-through. However, several factors argue for caution. Valuations in key leadership areas are demanding, with high-beta growth names priced close to perfection. Global macro risks also remain very much live, with geopolitical tensions, inflation, and central bank policy uncertainty all contributing to the choppy trading environment of recent months, and far from cleared through. Markets have voted for optimism today, but conviction remains fragile, and the balance between bulls and bears is far from settled.
